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Introduction
Health system reform is constant and global (1). Increasingly, 
most societies are preparing, legislating, implementing, 
assessing, or planning again the health system reform as a 
“continuous policy improvement” cycle. Across the globe, the 
threefold objectives of reform are familiar: increasing access to 
medical services, improving the quality of care, and controlling 
the growth of costs.  The “triple aim” of improving population 
health, lowering per capita costs, and improving the patient 
experience of care, knows no borders (2). While each national 
government chooses priorities based on their circumstances 
and needs, the problems and solutions are similar.
In the United States of America, versions of national health 
reform have been considered for more than 100 years with 
notable successes and failures, mostly the latter. Yet in 2010, 
President Barack Obama signed into law the Affordable Care 
Act (ACA)1, the most ambitious health reform program ever 
established in U.S. history. While many components were 
implemented between 2010–2013; January 1st, 2014 stands out 
as the point-of-no-return implementation date, and the repeal 
of this law is now impractical. 
Why and how did the U.S. reform happen? What does the ACA 
do?  What have been the principal implementation challenges? 
What is the future of reform in the U.S. and what does the ACA 
mean in the context of the global health reform? I will address 
these questions in this perspective.
Why and how did the U.S. health reform happen?
Before Barack Obama, other U.S. Presidents tried and failed 
to achieve the national health reform, most recently Harry 
Truman in the late 1940s and Bill Clinton in 1993–94, with 
1. Also known as the Patient Protection and Affordable Care Act (PPACA) and, 
unofficially, as “ObamaCare.” 
one exception.  In 1965, President Lyndon Johnson achieved 
passage of a law establishing both Medicare to provide public 
insurance for senior citizens and Medicaid to provide public 
insurance for some low-income families. Through the time of 
Johnson’s Administration, reform focused only on expanding 
access to health insurance. With the establishment of Medicare 
and Medicaid and the need to control the rising costs of these 
programs, all future reform efforts also sought to address the 
varying forms of cost control and quality improvement. 
Over more than three decades, a wealth of empirical evidence 
demonstrated that while the U.S. spent far more than that of 
any other advanced society on medical services, its quality, 
efficiency, and public health indicators were mediocre by 
international standards, and we were the only advanced nation 
to deny financial protection to many of our citizens from the 
costs of serious illness (3,4). 
Between 2005–2008, sensing a potential new reform opportunity, 
significant segments of American society began speaking for 
comprehensive national health reform, including organizations 
of physicians, hospitals, insurance companies, pharmaceutical 
and medical device manufacturers, labor unions, business 
groups, philanthropic foundations, and others.  In 2006, the 
state of Massachusetts adopted its own health reform plan to 
expand insurance to nearly all its residents, attracting support 
from both Republican and Democratic Party leaders (5). 
This success encouraged advocates that similar reform at the 
national level might overcome familiar political divisions. Key 
stakeholders insisted that the national reform must also address 
quality and costs, not just access, as Massachusetts had done. 
This ferment influenced the political sector.  Beginning in 2007, 
leading candidates for the Democratic Party’s presidential 
nomination began advancing comprehensive reform plans, 
notably Hillary Clinton and Barack Obama.  In early 2009, 
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newly inaugurated President Barack Obama began working 
with Democratic majorities in the U.S. Senate and House of 
Representatives to advance comprehensive reform legislation. 
In June, key committees in both chambers began advancing 
formal legislative drafts. As specific language replaced general 
principles, opposition and conflict emerged. In particular, 
Republican lawmakers began withdrawing from prior 
supportive stances to declare opposition. In the summer of 
2009, a new American political movement, named the “Tea 
Party,” composed of conservative and libertarian activists, 
focused on opposition to “ObamaCare” as their rallying point. 
By fall, nearly all Republican office holders had turned against 
the reform, leaving Democrats to push forward alone. 
A contentious and arduous legislative process resulted in the 
passage and signing of the ACA by President Obama on March 
23, 2010. Only Democrats supported the final passage as not 
a single Republican member of the Senate or House voted for 
the bill. The historic national health reform had been achieved, 
though on a shaky political foundation.
What does the Affordable Care Act do?
The ACA is the only significant federal law ever approved in the 
U.S. that attempts to achieve “comprehensive” health reform, 
meaning improvement on all three dimensions of access, quality 
and cost control (6). Just as a book is divided into chapters, a 
U.S. federal law is divided into “titles” and the ACA includes 
ten titles, 61 sub-titles, and 487 sections—each embodying at 
least one substantive public policy change. Table 1 provides a 
succinct outline of the ten titles to illustrate the law’s scope, 
breadth, and ambition.  In this brief summary, I will outline key 
reforms relating to access, quality, and costs (7). 
Access. The ACA’s essential purpose is to establish a new structure, 
so that nearly all citizens and legal residents will have access to 
affordable health insurance coverage.  This is achieved in two 
ways, expanded Medicaid for most low-income Americans, 
and subsidized private insurance for lower- and middle-income 
Americans who cannot obtain coverage elsewhere. 
Medicaid is a federal-state partnership, providing health 
coverage for many, though not all, low-income Americans. As 
approved in March 2010, the ACA expands coverage to nearly 
all low-income citizens who cannot obtain insurance elsewhere. 
However, a U.S. Supreme Court decision on the constitutionality 
of the ACA in June 2012 ruled that this expansion must 
be optional, not mandatory, for state governments. As of 
December 2012, 26 of the 50 states have elected to implement 
this expansion, though other states continue to consider and 
may join at any time.
Uninsured individuals with incomes too high to qualify for 
Medicaid can obtain private health insurance through new 
federal or state government-sponsored websites called Health 
Insurance Marketplaces. Those in lower or middle-income 
categories can obtain subsidies to lower the cost of premiums 
and related cost sharing. Higher-income, individuals, also can 
purchase coverage, though without financial assistance.  For 
the first time, insurance companies will be prohibited from 
considering an applicant’s medical history in the issuance, 
rating, or pricing of policies.
These and other changes represent the fundamental reform of 
U.S. health insurance, and are projected to lower the numbers 
of uninsured by 2019 from a projected 55 million to about 30 
million; the largest segment of remaining uninsured will be 
individuals eligible to enroll in coverage, though not signed 
up.  The ACA also contains a “mandate” on most individuals to 
purchase health insurance or to pay an annual tax penalty.
Quality and Cost Control. Though often considered 
independently, the ACA treats improvements in the quality, 
efficiency, and effectiveness of medical care as primary 
approaches to achieve both better quality and cost control. 
Table 2 outlines the key reforms included in the law.  Many 
ACA initiatives seek to move the U.S. financing system away 
from fee-for-service reimbursement that rewards medical 
providers for the volume and quantity of services, and toward 
a capitated or global payment model which rewards based on 
improvements in quality, efficiency, and outcomes of care.  The 
ACA establishes many new organizational forms including 
“Patient-centered medical homes” and “accountable care 
organizations”. Hospitals with high rates of “readmissions” 
of Medicare patients within 30 days after discharge as well 
as hospitals with high rates of hospital acquired infections 
are now subject to federal payment penalties. A new “Patient 
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Table 1. The essential structure of the ACA
Title Name Purpose
I Quality Affordable Coverage To expand private health insurance and strengthen insurance industry regulation
II Role of Public Programs To expand Medicaid for lower-income adults and families
III Improving Quality and Efficiency in Healthcare To improve the quality and efficiency of medical care, especially Medicare
IV
Prevention Chronic Disease and Improving Public 
Health
To create new initiatives to advance health promotion and disease prevention
V Healthcare Workforce To increase the numbers and improve the quality of the healthcare workforce
VI Transparency and Program Integrity To combat fraud and abuse, and to promote transparency in healthcare
VII Innovative Medical Therapies To permit the manufacture and sale of biopharmaceutical similar drugs (biosimilars)
VIII
Community Living Assistance Services and 
Supports
To create an insurance program to provide cash assistance to disabled persons (repealed on 
1/1/2013)
IX Revenue Provisions To establish new taxes and fees to pay for the programs and benefits created in the law
X Strengthening Healthcare for All Americans Composed of amendments and new additions to titles I-IX
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-Centered Outcomes Research Institute” (PCORI) is launching 
an ambitious research agenda on the comparative effectiveness 
of medical treatments and therapies.
Other provisions to control costs go beyond the delivery system 
reforms. New controls are established to prevent fraud and 
abuse. New structures emphasize health promotion and disease 
prevention, including the creation of a National Prevention 
Strategy (released in June 2011) (8). Other reforms will improve 
the size and effectiveness of the nation’s healthcare workforce. 
Title VII seeks to lower the growth in biopharmaceutical costs 
by authorizing the manufacturing, marketing and sale of the so-
called “biological similar” products. 
What have been the principal implementation challenges?
The ACA has experienced among the most controversial and 
conflictual implementations of any social welfare policy law 
in American history. Republican and conservative forces have 
mobilized in every conceivable political direction to thwart 
implementation backed by significant financial investments 
from opposition stakeholders and ideological adversaries. 
The most significant was the legal challenge that resulted 
in a ruling from the U.S. Supreme Court on June 28th, 2012 
(9). The court’s decision, by a narrow 5–4 vote, upheld the 
constitutionality of the entire law and the individual mandate, 
though requiring that the Medicaid expansion be optional for 
states.  Other legal challenges have failed to reach the high 
court, though some are still in process.  The U.S. House of 
Representatives, controlled by a Republican majority since early 
2011, has taken more than 45 votes to repeal or undermine the 
law—none of which passed the Democratic-controlled Senate; 
the House has been able to impede the flow of funding for 
implementation of many ACA elements.
The partnership envisioned in the ACA between the federal 
and state governments has been challenging, especially in states 
with Republican governors. Only half the states have adopted 
the Medicaid expansion in spite of generous federal financing, 
and fewer than 20 have chosen to operate their own health 
insurance marketplaces, opting for the federal government 
to establish these entities. A faulty and flawed launch of the 
marketplace websites in October 2013 became a serious, self-
inflicted wound by the Obama Administration as millions of 
potential customers were unable to enroll; while problems have 
been corrected, reputational damage endures. 
The ACA’s essential implementation date has always been 
January 1st, 2014 when the Medicaid expansions, the private 
insurance subsidies, the individual mandate, and the health 
insurance regulatory reforms all took effect.  With the launch of 
these reforms, complete repeal of the ACA is now improbable.
What is the future of U.S. health reform and what does the 
ACA mean for global reform?
In the U.S., the passage of any significant law is the end of a 
lengthy legislative process, and the initiation of an ongoing 
implementation and improvement process as the nation comes 
to understand the law’s advantages, disadvantages, flaws, and 
errors. The prior major federal health law that established 
Medicare and Medicaid in 1965 has been subject to continuous 
debate, review and amendment for nearly 50 years. So it will be 
with the ACA as the nation’s public and healthcare stakeholders 
evaluate its successes and failure, and as lawmakers modify the 
law to meet the changing needs of a dynamic society.
The ACA’s access and insurance coverage reforms represent an 
effort by the U.S. to catch up with the health financial security 
already guaranteed to residents of all other OECD nations, as 
well as by a growing number of less advanced nations including 
Mexico, Thailand, and Turkey. While these reforms are of 
immense consequences to the U.S. public, they offer no lessons 
for other nations, all of which cover their citizens with far less 
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Table 2.  Examples of quality and system reform innovations in the ACA
ACA Title/ Section Name Purpose
III/3022 Accountable Care Organizations
New vertically-integrated provider organizations to assume the risk for patient 
outcomes and health
II/2703 Patient-Centered Medical Homes Coordinated primary care for low-income and chronically ill
III/3025 Hospital Readmissions Penalties on hospitals with high rates of readmissions within 30 days of discharge
III/3008 Hospital-Acquired Infections Penalties on hospitals with high rates of healthcare associated infections
VI/6301-2
Patient-Centered Outcomes Research 
Institute
New institute to commission research on comparative effectiveness of therapies and 
treatments
III/3002 Physician Quality Reporting Physicians must report quality data or face financial penalties
I/3403 Administrative Simplification Reducing paperwork and administrative burdens
VII Biosimilar Drugs Allowing manufacturing, marketing and sale of biopharmaceutical similar drugs
III/3001 Hospital Value-Based Purchasing Program Payments to hospitals will be tied to performance on quality measures
III/3011 National Quality Strategy
Coordinated and annually updated strategy on national healthcare quality 
improvement
IV/4001 National Prevention Strategy National coordinated strategy to emphasize health promotion and disease prevention
V/5011 National Workforce Commission
National data collection and analysis and policy recommendations to improve the 
quantity and quality of the workforce
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overhead, administrative bureaucracy, or complexity. 
The ACA’s efforts to improve the efficiency, effectiveness, and 
quality of medical care demand attention, and will be watched 
and evaluated by health system reformers around the globe for 
years to come. The ideas and concepts, embedded in the ACA’s 
health system reforms, represent the cutting edge thinking about 
health system transformation and continuous improvement. 
The U.S. health system is one of the world’s leading innovation 
labs in reforming medical care delivery, partially because our 
society is so open to recognizing our health system’s faults 
and deficiencies. The U.S. health system underperforms other 
societies in “top-down” governance and management—
lacking a “controlling legal authority” in our federalized and 
Balkanized system. Alternately, the U.S. system outperforms 
many other societies in “bottom-up” innovation and localized 
responsibility.  Our hospitals floors, research labs, insurance 
agencies, technology innovators, philanthropies, and others, are 
hotbeds of ideas and experimentation.  So many ideas, so much 
knowledge about what “works” comes from the U.S. system. 
For far too long, the U.S. public’s interest in health policy has 
stopped at the nation’s borders, characterized by a narrow and 
self-defeating mindset that we have nothing to learn from 
other nations’ systems. That, too, is changing, as evidenced by 
the Commonwealth Fund’s International Health Policy Center 
(10). I hope the exchanges and cross learning will grow more 
robustly in the years ahead.
Ethical issues
Not applicable.
Competing interests
The author declares that he has no competing interests. 
Author’s contribution
JEM is the single author of the manuscript.
References
1. Frenk J. The global health system: strengthening national health 
systems as the next step for global progress. PLoS Med 2010; 7: 
e1000089. 
2. Dentzer S. The Triple Aim Goes Global. Health Aff (Millwood) 
2013; 32: 638.
3. Institute of Medicine. Crossing the Quality Chasm [internet].  2001. 
Available from: http://www.iom.edu/Reports/2001/Crossing-the-
Quality-Chasm-A-New-Health-System-for-the-21st-Century.aspx.
4. Institute of Medicine. Coverage Matters: Insurance and Health 
Care. Washington, DC: National Academies Press; 2001.  
5. McDonough J, Rosman B, Phelps F, Shannon M. The Third 
Wave of Massachusetts Health Care Access Reform. Health Aff 
(Millwood) 2006; 25: W42–431.
6. Affordable Care Act [internet]. Available from: http://www.hhs.gov/
healthcare/rights/law/  
7. McDonough J. Inside National Health Reform. Berkely, California: 
University of California Press and the Milbank Fund; 2011.
8. U.S. Surgeon General. National Prevention Strategy [internet]. 
Available from: http://www.surgeongeneral.gov/initiatives/prevention/
strategy/ 
9. McDonough J. The Road Ahead for the Affordable Care Act.  N 
Engl J Med 2012; 367: 199–201.
10. Commonwealth Fund. International Health Policy Center [internet]. 
Available from: http://www.commonwealthfund.org/Topics/International-
Health-Policy.aspx 
